|
News, Views
|
Category: News, Views
A Learning System, Deriving Value from Products Previously Studied
Many investigational products previously pursued by biopharmaceutical industry have value for small patient groups. It is as important to glean value from existing products and knowledge as it is to pursue new treatments. At a minimum, this could help the industry proactively face the issue of diminishing returns. Drew Smith’s article on rising cost and declining discovery rates being the…